Alan Olby

Alan Olby

Director of Finance/CFO at INSPIRATION HEALTHCARE GROUP PLC

Net worth: 15 557 $ as of 2024-03-30

53 year
Health Technology
Commercial Services
Finance

Profile

Alan Musgrave Olby is currently the Chief Financial Officer & Director at Inspiration Healthcare Group Plc since 2023.
He also holds a current position at Deloitte Touche Tohmatsu Services LLC since 2004.
Previously, he worked as the Chief Financial Officer & Executive Director at Sinclair Pharma Ltd.
from 2005 to 2022.
He also held various director positions at Sinclair Pharmaceutical España SL (Spain), Sinclair Pharmaceuticals Ltd., Sinclair Pharma Holdings Ltd., Sinclair Pharma Management Ltd., and IS Pharmaceuticals Ltd.
Additionally, he worked as the Group Financial Controller at Xenova Group Plc and KS Biomedix Plc.
He started his career as an Audit Manager at Baker Tilly & Co. Ltd.
and Finance Manager at Deloitte LLP (United Kingdom).

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-10-15 43,211 ( 0.06% ) 15 557 $ 2024-03-30

Alan Olby active positions

CompaniesPositionStart
INSPIRATION HEALTHCARE GROUP PLC Director of Finance/CFO 2023-06-11
All active positions of Alan Olby

Former positions of Alan Olby

CompaniesPositionEnd
SINCLAIR PHARMA PLC Director of Finance/CFO -
Director of Finance/CFO 2009-10-06
IS Pharmaceuticals Ltd. Director/Board Member -
Director/Board Member -
Director/Board Member -
See the detail of Alan Olby's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Alan Olby's experience

Connections

42

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
INSPIRATION HEALTHCARE GROUP PLC

Health Technology

Private companies11

Commercial Services

Health Technology

Commercial Services

KS Biomedix Plc

Consumer Non-Durables

Commercial Services

Health Technology

Health Technology

Finance

Finance

IS Pharmaceuticals Ltd.

See company connections